CAMBRIDGE HEART INC (CAMH)
We are engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. Using innovative technologies, we are addressing a key problem in cardiac diagnosis—the identification of those at risk of sudden cardiac death. Our products incorporate our proprietary technology for the measurement of Microvolt T-Wave Alternans (“MTWA”), and were the first diagnostic tools cleared by the U.S. Food and Drug Administration, which we call the FDA, to non-invasively measure Microvolt levels of T-Wave Alternans to predict the risk of sudden cardiac death. Microvolt T-Wave Alternans is an extremely subtle beat-to-beat fluctuation i...
To see the headquarters in Google Street View &trade, drag this yellow guy:
over to the red pointer: 
Contact Information:
| Business Address: | 100 Ames Pond Drive, Suite 100, Tewksbury, MA 01876, United States |
| Mailing Address: | - |
| Phone: | 978-654-7600 |
| Fax: | 978-654-4501 |
| Website: | http//www.cambridgeheart.com |
Company Details:
| Symbol: | CAMH |
| SIC: | - |
| State location: | MA |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 26 |
| Type: | - |
Key executives:
| Name | Age | Position |
|---|---|---|
| Ali Haghighi-Mood Ph.D. | 61 | Chief Operating Officer and Exec. VP |
| David A. Chazanovitz | 70 | Sec., Director and Chairman of Nominating Committee |
| Laurence Blumberg MD | 2021 | Founder, VP of Bus. Devel. |
| Richard Cohen M.D., Ph.D. | 70 | Founder, Consultant |
| Robert P. Khederian | 68 | Chairman, Interim Chief Exec. Officer, Interim Pres, Member of Nominating Committee and Member of Compensation Committee |
